AnalystsSwayampakula RamakanthSwayampakula Ramakanth's Stock Forecasts
AnalystsSwayampakula Ramakanth
Analyst Ranking
Bottom 5%
#3949 out of 4126 analysts
Average Return
-4.96%
Win Rate
34%43 out of 126
Risk vs Reward
Poor
Good
Swayampakula Ramakanth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Electrocore IncECOR | +362.22% | $0.45 | $2.08 | 2020-03-24 - 2021-03-24 | Buy |
Edap Tms SaEDAP | +299.53% | $2.15 | $8.57 | 2020-04-01 - 2021-04-01 | Buy |
Aveo Pharmaceuticals IncAVEO | +291.54% | $2.60 | $10.18 | 2020-03-18 - 2021-03-18 | Buy |
Electrocore IncECOR | +254.41% | $0.60 | $2.13 | 2020-03-10 - 2021-03-10 | Buy |
Intelgenx Technologies CorpIGXT | +238.46% | $0.13 | $0.44 | 2020-03-30 - 2021-03-30 | Buy |
Swayampakula Ramakanth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunoprecise Antibodies LtdIPA | 1 | Buy | $9.00 | +69.49% | Initiates Coverage On | 3 days ago |
X4 Pharmaceuticals IncXFOR | 4 | Buy | $5.00 | +262.32% | Maintains | 5 days ago |
Edap Tms SaEDAP | 5 | Buy | $12.00 | +5.73% | Maintains | 17 days ago |
Immunogen IncIMGN | 2 | Buy | $20.00 | +265.63% | Maintains | 19 days ago |
Mediwound LtdMDWD | 2 | Buy | $5.50 | +259.95% | Maintains | 19 days ago |
Rewalk Robotics LtdRWLK | 3 | Buy | $3.00 | +227.51% | Maintains | 20 days ago |
Vericel CorpVCEL | 4 | Buy | $35.00 | +46.75% | Maintains | 25 days ago |
Alx Oncology Holdings IncALXO | 2 | Buy | $65.00 | +472.69% | Maintains | a month ago |
Medicenna Therapeutics CorpMDNA | 5 | Buy | $2.50 | +352.90% | Maintains | a month ago |
Codexis IncCDXS | 8 | Buy | $15.00 | +164.55% | Maintains | a month ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $4.00 | +113.90% | Maintains | a month ago |
Surface Oncology IncSURF | 3 | Buy | $6.00 | +512.87% | Maintains | a month ago |
Personalis IncPSNL | 6 | Buy | $13.00 | +352.96% | Maintains | a month ago |
Aveo Pharmaceuticals IncAVEO | 4 | Hold | $15.00 | +0.54% | Downgrades | 2 months ago |
Mimedx Group IncMDXG | 3 | Buy | $8.00 | +135.29% | Maintains | 3 months ago |
In8bio IncINAB | 1 | Buy | $14.00 | +560.38% | Initiates Coverage On | 3 months ago |
Calithera Biosciences IncCALA | 2 | Buy | $8.00 | +308.16% | Upgrades | 3 months ago |
Diffusion Pharmaceuticals IncDFFN | 4 | Buy | $9.50 | +55.74% | Upgrades | 4 months ago |
Ocugen IncOCGN | 7 | Buy | $6.00 | +272.67% | Maintains | 4 months ago |
Harpoon Therapeutics IncHARP | 2 | Buy | $7.00 | +847.23% | Maintains | 4 months ago |
Vor Biopharma IncVOR | 2 | Buy | $20.00 | +304.04% | Maintains | 4 months ago |
Bioatla IncBCAB | 2 | Buy | $20.00 | +90.11% | Maintains | 4 months ago |
Asensus Surgical IncASXC | 2 | Buy | $3.00 | +637.10% | Maintains | 4 months ago |
Delcath Systems IncDCTH | 2 | Buy | $19.00 | +533.33% | Maintains | 4 months ago |
Precigen IncPGEN | 1 | Buy | $6.00 | +217.46% | Maintains | 4 months ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $11.00 | +1,124.94% | Maintains | 4 months ago |
Bicycle Therapeutics PLCBCYC | 3 | Buy | $57.00 | +79.64% | Maintains | 4 months ago |
Corcept Therapeutics IncCORT | 3 | Buy | $33.00 | +32.11% | Maintains | 4 months ago |
Ekso Bionics Holdings IncEKSO | 1 | Buy | $9.00 | +637.70% | Maintains | 4 months ago |
Vascular Biogenics LtdVBLT | 4 | Hold | N/A | N/A | Downgrades | 5 months ago |
Celularity IncCELU | 1 | Buy | $15.00 | +757.14% | Initiates Coverage On | 5 months ago |
Pulse Biosciences IncPLSE | 5 | Hold | N/A | N/A | Downgrades | 7 months ago |
Oncorus IncONCR | 1 | Buy | $7.00 | +1,425.05% | Initiates Coverage On | 8 months ago |
Hookipa Pharma IncHOOK | 4 | Buy | $8.00 | +716.33% | Maintains | 10 months ago |
Electrocore IncECOR | 3 | Buy | $2.75 | +674.65% | Maintains | a year ago |
Iteos Therapeutics IncITOS | 2 | Buy | $54.00 | +169.60% | Maintains | a year ago |
Trillium Therapeutics IncTRIL | 3 | Hold | $18.50 | N/A | Downgrades | a year ago |
Sesen Bio IncSESN | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $6.00 | N/A | Maintains | a year ago |
Janux Therapeutics IncJANX | 1 | Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Kindred Biosciences IncKIN | 3 | Hold | $9.25 | N/A | Downgrades | a year ago |
Alaunos Therapeutics IncTCRT | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Isoray IncISR | 2 | Buy | $2.10 | N/A | Maintains | 2 years ago |
Collplant Biotechnologies LtdCLGN | 2 | Buy | $26.00 | N/A | Maintains | 2 years ago |
Inmune Bio IncINMB | 2 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Intelgenx Technologies CorpIGXT | 1 | Buy | $0.50 | N/A | Reiterates | 3 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $3.50 | N/A | Maintains | 3 years ago |
Leap Therapeutics IncLPTX | 1 | Buy | $2.50 | N/A | Maintains | 3 years ago |
Verastem IncVSTM | 1 | Buy | $2.75 | N/A | Maintains | 3 years ago |
Alphatec Holdings IncATEC | 2 | Buy | $9.50 | N/A | Reiterates | 3 years ago |
Redhill Biopharma LtdRDHL | 1 | Buy | $14.00 | N/A | Reiterates | 3 years ago |
Forty Seven IncFTSV | 1 | Hold | $95.50 | N/A | Downgrades | 3 years ago |
Correvio Pharma CorpCORV | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Advaxis IncADXS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Aratana Therapeutics IncPETX | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Idera Pharmaceuticals IncIDRA | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 5 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Buy | $14.00 | N/A | Assumes | 5 years ago |
Seaspine Holdings CorpSPNE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 5 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.